Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kemmler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fresenius' Journal of Analytical Chemistry|January 5, 2002
Quantification of corrosion phenomena in plastic processing machinesB Kemmler, P Hoffmann, M Cremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2011
Elevated tumor-associated antigen expression suppresses variant peptide vaccine responsesCharles B Kemmler, Eric T Clambey, Ross M Kedl, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigensKimberly R Jordan, Rachel H McMahan, Charles B Kemmler, et al.
Cancer Research|November 20, 2012
Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigensJonathan D Buhrman, Kimberly R Jordan, Lance U'ren, et al.
Vaccine|March 11, 2008
Age-dependent tolerance to an endogenous tumor-associated antigenJennifer A McWilliams, Richard T Sullivan, Kimberly R Jordan, et al.
The American Journal of Emergency Medicine|March 18, 2021
Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delayCharles B Kemmler, Rohit B Sangal, Craig Rothenberg, et al.
AEM Education and Training|July 5, 2021
A 1-year training program in emergency medicine for physicians in Karachi, Pakistan: Evaluation of learner and program outcomesCharles B Kemmler, Syed Ghazanfar Saleem, Saima Ali, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fresenius' Journal of Analytical Chemistry|January 5, 2002
Quantification of corrosion phenomena in plastic processing machinesB Kemmler, P Hoffmann, M Cremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2011
Elevated tumor-associated antigen expression suppresses variant peptide vaccine responsesCharles B Kemmler, Eric T Clambey, Ross M Kedl, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigensKimberly R Jordan, Rachel H McMahan, Charles B Kemmler, et al.
Cancer Research|November 20, 2012
Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigensJonathan D Buhrman, Kimberly R Jordan, Lance U'ren, et al.
Vaccine|March 11, 2008
Age-dependent tolerance to an endogenous tumor-associated antigenJennifer A McWilliams, Richard T Sullivan, Kimberly R Jordan, et al.
The American Journal of Emergency Medicine|March 18, 2021
Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delayCharles B Kemmler, Rohit B Sangal, Craig Rothenberg, et al.
AEM Education and Training|July 5, 2021
A 1-year training program in emergency medicine for physicians in Karachi, Pakistan: Evaluation of learner and program outcomesCharles B Kemmler, Syed Ghazanfar Saleem, Saima Ali, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
Pageof 1